ExLibris header image
SFX Logo
Title: Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
Source:

Plos One [1932-6203] Jang, Jeong yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Firpi, Roberto J J. "Management of viral hepatitis in hematologic malignancies." Blood Reviews 22.3 (2008): 117-26. Link to SFX for this item
2. Weinbaum, CM. "Recommendations for identification and public health management of persons." Morbidity and mortality weekly report. Recommendations and reports 57.RR-8 (2008): 1-. Link to SFX for this item
3. Brodsky, Robert A A. "Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria." Blood 111.4 (2008): 1840-7. Link to SFX for this item
4. Firpi, R. "Viral hepatitis: manifestations and management strategy." Hematology (2006): 375-80. Link to SFX for this item
5. Fioredda, F. "HCV infection in very-long-term survivors after cancer chemotherapy and bone marrow transplantation: a single-center experience." Journal of pediatric hematology/oncology 27.9 (2005): 481-5. Link to SFX for this item
6. Nathan, Debbie M M. "Hepatitis B and C virus infections and anti-tumor necrosis factor-(alpha) therapy: Guidelines for clinical approach." Journal of gastroenterology and hepatology 21.9 (2006): 1366-1371. Link to Full Text for this item Link to SFX for this item
7. Muus, P. "Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria." British journal of haematology 142.2 (2008): 263-272. Link to Full Text for this item Link to SFX for this item
8. Bartsch, H. "Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair." Langenbeck's archives of surgery 391.5 (2006): 499-510. Link to SFX for this item
9. Chuang, E. "Biomedicines to reduce inflammation but not viral load in chronic HCV--what's the sense?" Trends in biotechnology 22.10 (2004): 517-23. Link to SFX for this item
10. Vitelli, V. "Crystallography on curved surfaces." Proceedings of the National Academy of Sciences of the United States of America 103.33 (2006): 12323-12328. Link to Full Text for this item Link to SFX for this item
11. Brodsky, Robert A A. "Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria." Blood Reviews 22.2 (2007): 65-74. Link to SFX for this item
12. Freed GL, Gary L L. "Use of a new combined vaccine in pediatric practices." Pediatrics 118.2 (2006): 767-7. Link to SFX for this item
13. Hino, O. "Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma." Journal of gastroenterology 37.11 (2002): 883-7. Link to Full Text for this item Link to SFX for this item
14. Radford Smith, Graham R. "Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease." Journal of gastroenterology and hepatology 22.8 (2007): 1306-1312. Link to Full Text for this item Link to SFX for this item
15. Nguyen, John S S. "Clinical problem-solving. More than meets the eye." The New England journal of medicine 355.10 (2006): 1048-52. Link to SFX for this item
16. Takita, M. "Eculizumab in paroxysmal nocturnal hemoglobinuria." The New England journal of medicine 355.26 (2007): 2787-8. Link to SFX for this item
17. El-Sayed, Manal H H. "Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation." European journal of gastroenterology & hepatology 16.12 (2004): 1347-54. Link to SFX for this item
18. Koike, K. "Antiviral treatment of hepatitis C: present status and future prospects." Journal of infection and chemotherapy 12.5 (2006): 227-32. Link to SFX for this item
19. Desai, Sheetal B B. "Problems encountered during anti-tumour necrosis factor therapy." Baillière's best practice & research. Clinical rheumatology 20.4 (2006): 757-90. Link to SFX for this item
20. Rother, Russell P P. "Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria." The New England journal of medicine 350.6 (2004): 552-9. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced